

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.27955966 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.06675783 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.60093052 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.24496508 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12466153 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.11571703 |
| 7 | glutamate secretion (GO:0014047) | 5.01226652 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.98229617 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81742014 |
| 10 | vocalization behavior (GO:0071625) | 4.81022618 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.71883789 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.52688108 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.30621948 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.28485102 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 4.27506052 |
| 16 | postsynaptic membrane organization (GO:0001941) | 4.20276795 |
| 17 | sodium ion export (GO:0071436) | 4.19896629 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.18166357 |
| 19 | exploration behavior (GO:0035640) | 4.13239450 |
| 20 | protein localization to synapse (GO:0035418) | 4.12767744 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.12016920 |
| 22 | proline transport (GO:0015824) | 4.10383738 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.07715913 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02217935 |
| 25 | cerebellar granule cell differentiation (GO:0021707) | 3.95150902 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.89634512 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.87304814 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85706438 |
| 29 | neuronal ion channel clustering (GO:0045161) | 3.83234230 |
| 30 | amino acid import (GO:0043090) | 3.82104612 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.78254113 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.76328039 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.74636011 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72018188 |
| 35 | neuronal action potential propagation (GO:0019227) | 3.71307048 |
| 36 | synaptic transmission, glutamatergic (GO:0035249) | 3.61064166 |
| 37 | synaptic vesicle endocytosis (GO:0048488) | 3.52401519 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.51232893 |
| 39 | long-term memory (GO:0007616) | 3.50958959 |
| 40 | regulation of synapse maturation (GO:0090128) | 3.50572480 |
| 41 | cell communication by electrical coupling (GO:0010644) | 3.49993429 |
| 42 | neuromuscular process controlling balance (GO:0050885) | 3.47689395 |
| 43 | neuron cell-cell adhesion (GO:0007158) | 3.47312412 |
| 44 | regulation of ARF protein signal transduction (GO:0032012) | 3.45900394 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.44374620 |
| 46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.43470078 |
| 47 | glycine transport (GO:0015816) | 3.42432582 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.37871847 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.36936307 |
| 50 | neurotransmitter transport (GO:0006836) | 3.36729552 |
| 51 | positive regulation of dendritic spine development (GO:0060999) | 3.36170199 |
| 52 | dendritic spine morphogenesis (GO:0060997) | 3.35635815 |
| 53 | neuron-neuron synaptic transmission (GO:0007270) | 3.32836748 |
| 54 | positive regulation of membrane potential (GO:0045838) | 3.31017418 |
| 55 | neuromuscular process controlling posture (GO:0050884) | 3.26851147 |
| 56 | dendrite morphogenesis (GO:0048813) | 3.26677752 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.22207899 |
| 58 | dendritic spine organization (GO:0097061) | 3.21720527 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.20981663 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.20230856 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.18697718 |
| 62 | vesicle transport along microtubule (GO:0047496) | 3.17504701 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.16998780 |
| 64 | membrane depolarization during action potential (GO:0086010) | 3.15068023 |
| 65 | regulation of neurotransmitter levels (GO:0001505) | 3.14391813 |
| 66 | acidic amino acid transport (GO:0015800) | 3.13414748 |
| 67 | central nervous system myelination (GO:0022010) | 3.12767125 |
| 68 | axon ensheathment in central nervous system (GO:0032291) | 3.12767125 |
| 69 | response to auditory stimulus (GO:0010996) | 3.11277176 |
| 70 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.11179570 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.08194712 |
| 72 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.05669553 |
| 73 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04309506 |
| 74 | potassium ion import (GO:0010107) | 3.03671133 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03306553 |
| 76 | alanine transport (GO:0032328) | 3.02990885 |
| 77 | cell migration in hindbrain (GO:0021535) | 3.02849421 |
| 78 | neuromuscular synaptic transmission (GO:0007274) | 3.01351468 |
| 79 | establishment of synaptic vesicle localization (GO:0097480) | 3.00257961 |
| 80 | synaptic vesicle transport (GO:0048489) | 3.00257961 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99104791 |
| 82 | presynaptic membrane assembly (GO:0097105) | 2.98872889 |
| 83 | auditory behavior (GO:0031223) | 2.98124621 |
| 84 | L-amino acid import (GO:0043092) | 2.97522584 |
| 85 | presynaptic membrane organization (GO:0097090) | 2.96787943 |
| 86 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.95875024 |
| 87 | clathrin coat assembly (GO:0048268) | 2.94487201 |
| 88 | long-term synaptic potentiation (GO:0060291) | 2.94426392 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.94047418 |
| 90 | cerebellar Purkinje cell layer development (GO:0021680) | 2.93454799 |
| 91 | regulation of dendritic spine development (GO:0060998) | 2.93245445 |
| 92 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.93121698 |
| 93 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91756418 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 2.91642695 |
| 95 | regulation of vesicle fusion (GO:0031338) | 2.89987916 |
| 96 | membrane depolarization (GO:0051899) | 2.88584373 |
| 97 | neuron recognition (GO:0008038) | 2.87171339 |
| 98 | cellular sodium ion homeostasis (GO:0006883) | 2.86932197 |
| 99 | synaptic transmission (GO:0007268) | 2.83376769 |
| 100 | prepulse inhibition (GO:0060134) | 2.82930082 |
| 101 | signal release (GO:0023061) | 2.81501293 |
| 102 | potassium ion homeostasis (GO:0055075) | 2.80265387 |
| 103 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.79226920 |
| 104 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.78977763 |
| 105 | neuromuscular process (GO:0050905) | 2.78198100 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77763606 |
| 107 | response to pheromone (GO:0019236) | 2.77295582 |
| 108 | vesicle docking involved in exocytosis (GO:0006904) | 2.77184014 |
| 109 | membrane hyperpolarization (GO:0060081) | 2.76895847 |
| 110 | organelle transport along microtubule (GO:0072384) | 2.76338007 |
| 111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.76233267 |
| 112 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.75605987 |
| 113 | axonal fasciculation (GO:0007413) | 2.74700372 |
| 114 | innervation (GO:0060384) | 2.73736108 |
| 115 | positive regulation of synaptic transmission (GO:0050806) | 2.73387081 |
| 116 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.71928975 |
| 117 | transmission of nerve impulse (GO:0019226) | 2.71185005 |
| 118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.69295819 |
| 119 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.67984540 |
| 120 | regulation of synaptic transmission (GO:0050804) | 2.67927959 |
| 121 | establishment of nucleus localization (GO:0040023) | 2.66756291 |
| 122 | axon cargo transport (GO:0008088) | 2.66331620 |
| 123 | cell communication involved in cardiac conduction (GO:0086065) | 2.63138304 |
| 124 | mating behavior (GO:0007617) | 2.61869268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79170853 |
| 2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80716527 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79993797 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75672285 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74240912 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.66844385 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57303138 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52056691 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45480021 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45480021 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41293052 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38649392 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33938306 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32914604 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24368933 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21783076 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20108975 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15939300 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14316286 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10047752 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04581130 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01822691 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94052321 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92161733 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87127448 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83290720 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79391193 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72482944 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70443191 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66500253 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59266681 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54446596 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52894579 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47440173 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43483637 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.38582998 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36642356 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36200825 |
| 39 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34838797 |
| 40 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33771366 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33045202 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29055496 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29041686 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27239467 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25869130 |
| 46 | AR_19668381_ChIP-Seq_PC3_Human | 1.25456112 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25002293 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23743268 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22135746 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20010283 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18548395 |
| 52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16324281 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15518699 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14489541 |
| 55 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.14430120 |
| 56 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13836352 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13700329 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13279540 |
| 59 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12638869 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10600895 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09545687 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08723379 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08092711 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07660907 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06982726 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06469872 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05889172 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04818637 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02653605 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02506374 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01694538 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99871418 |
| 73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99101350 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98796999 |
| 75 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98693380 |
| 76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98384951 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98149609 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97808588 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97721868 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97253555 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96665312 |
| 82 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96419424 |
| 83 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96271314 |
| 84 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95910349 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94584598 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94487843 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94051352 |
| 88 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93811721 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92727020 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92061718 |
| 91 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90960759 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90552344 |
| 93 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89999914 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89202881 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88119230 |
| 96 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88069091 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87766723 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85555472 |
| 99 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85447582 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84844382 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84396266 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83872612 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83763706 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83568019 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83498243 |
| 106 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83478385 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82837864 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82413969 |
| 109 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82224618 |
| 110 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81849559 |
| 111 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81223639 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80724746 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80669317 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79895061 |
| 115 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.76984468 |
| 116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74763902 |
| 117 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73082804 |
| 118 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.72959709 |
| 119 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.72501091 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71233055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.89968554 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.06192097 |
| 3 | MP0003880_abnormal_central_pattern | 3.72309109 |
| 4 | MP0004270_analgesia | 3.53634643 |
| 5 | MP0009046_muscle_twitch | 3.18701525 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.17035041 |
| 7 | MP0009745_abnormal_behavioral_response | 3.14118448 |
| 8 | MP0002064_seizures | 3.09867406 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.95145665 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.72038414 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.65192604 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.56630234 |
| 13 | MP0002822_catalepsy | 2.54538048 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.51453086 |
| 15 | MP0004858_abnormal_nervous_system | 2.38232059 |
| 16 | MP0002272_abnormal_nervous_system | 2.28250707 |
| 17 | MP0001486_abnormal_startle_reflex | 2.25655826 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.24299731 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.22717478 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.12199355 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.07431716 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.02473720 |
| 23 | MP0008569_lethality_at_weaning | 2.01384119 |
| 24 | MP0003329_amyloid_beta_deposits | 1.99717100 |
| 25 | MP0002736_abnormal_nociception_after | 1.98611232 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.97537785 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.95245537 |
| 28 | MP0001970_abnormal_pain_threshold | 1.89558533 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.86944833 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.81705099 |
| 31 | MP0003879_abnormal_hair_cell | 1.71711686 |
| 32 | MP0004924_abnormal_behavior | 1.60006376 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.60006376 |
| 34 | MP0002184_abnormal_innervation | 1.59789147 |
| 35 | MP0003633_abnormal_nervous_system | 1.56432025 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.56371112 |
| 37 | MP0000955_abnormal_spinal_cord | 1.47781559 |
| 38 | MP0000778_abnormal_nervous_system | 1.47596704 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.41640253 |
| 40 | MP0004885_abnormal_endolymph | 1.39765341 |
| 41 | MP0003690_abnormal_glial_cell | 1.39571062 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.38507838 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.34624894 |
| 44 | MP0000604_amyloidosis | 1.34346555 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.34326434 |
| 46 | MP0000751_myopathy | 1.29021004 |
| 47 | MP0003787_abnormal_imprinting | 1.28913171 |
| 48 | MP0003075_altered_response_to | 1.27261233 |
| 49 | MP0001984_abnormal_olfaction | 1.26854896 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.25426537 |
| 51 | MP0003631_nervous_system_phenotype | 1.25224132 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.23035340 |
| 53 | MP0004510_myositis | 1.22917052 |
| 54 | MP0002090_abnormal_vision | 1.20184305 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.18595347 |
| 56 | MP0004130_abnormal_muscle_cell | 1.13888352 |
| 57 | MP0004147_increased_porphyrin_level | 1.12787330 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.10254782 |
| 59 | MP0003634_abnormal_glial_cell | 1.10252404 |
| 60 | MP0003283_abnormal_digestive_organ | 1.09641981 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.09089425 |
| 62 | MP0002229_neurodegeneration | 1.08200489 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.08197465 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.07925502 |
| 65 | MP0003123_paternal_imprinting | 1.03769426 |
| 66 | MP0001529_abnormal_vocalization | 1.03572726 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.02495410 |
| 68 | MP0000013_abnormal_adipose_tissue | 0.99924852 |
| 69 | MP0002152_abnormal_brain_morphology | 0.98163694 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.95500545 |
| 71 | MP0003122_maternal_imprinting | 0.94789568 |
| 72 | MP0003632_abnormal_nervous_system | 0.92537874 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.91517837 |
| 74 | MP0004142_abnormal_muscle_tone | 0.91288345 |
| 75 | MP0008874_decreased_physiological_sensi | 0.91209559 |
| 76 | MP0004233_abnormal_muscle_weight | 0.90145406 |
| 77 | MP0005535_abnormal_body_temperature | 0.89968931 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.89079080 |
| 79 | MP0001177_atelectasis | 0.86634834 |
| 80 | MP0008872_abnormal_physiological_respon | 0.83398187 |
| 81 | MP0003303_peritoneal_inflammation | 0.82655945 |
| 82 | MP0004085_abnormal_heartbeat | 0.82143270 |
| 83 | MP0000920_abnormal_myelination | 0.80719225 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.73548588 |
| 85 | MP0001188_hyperpigmentation | 0.72001908 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.71683409 |
| 87 | MP0003121_genomic_imprinting | 0.69989226 |
| 88 | MP0000747_muscle_weakness | 0.66826220 |
| 89 | MP0005171_absent_coat_pigmentation | 0.66151077 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.65821468 |
| 91 | MP0003045_fibrosis | 0.64567424 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.63518620 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.62267056 |
| 94 | MP0005409_darkened_coat_color | 0.60843622 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.60529280 |
| 96 | MP0004484_altered_response_of | 0.60249308 |
| 97 | MP0001905_abnormal_dopamine_level | 0.60002780 |
| 98 | MP0004742_abnormal_vestibular_system | 0.57662772 |
| 99 | MP0005166_decreased_susceptibility_to | 0.56590314 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.54532254 |
| 101 | MP0005499_abnormal_olfactory_system | 0.54532254 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.53089928 |
| 103 | MP0004043_abnormal_pH_regulation | 0.52484584 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.50998814 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.50501923 |
| 106 | MP0002082_postnatal_lethality | 0.49993944 |
| 107 | MP0010770_preweaning_lethality | 0.49993944 |
| 108 | MP0001943_abnormal_respiration | 0.49939418 |
| 109 | MP0005253_abnormal_eye_physiology | 0.49832537 |
| 110 | MP0010769_abnormal_survival | 0.49772547 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.49683004 |
| 112 | MP0005448_abnormal_energy_balance | 0.49560246 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.49057135 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.49004965 |
| 115 | MP0009840_abnormal_foam_cell | 0.48876516 |
| 116 | MP0010768_mortality/aging | 0.48655908 |
| 117 | MP0003956_abnormal_body_size | 0.47067898 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.46646184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.11793201 |
| 2 | Focal motor seizures (HP:0011153) | 5.93362479 |
| 3 | Focal seizures (HP:0007359) | 5.11925836 |
| 4 | Visual hallucinations (HP:0002367) | 5.04327544 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.32920178 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.13354163 |
| 7 | Action tremor (HP:0002345) | 4.10235358 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.96778367 |
| 9 | Febrile seizures (HP:0002373) | 3.77552128 |
| 10 | Atonic seizures (HP:0010819) | 3.61205406 |
| 11 | Mutism (HP:0002300) | 3.59131771 |
| 12 | Ankle clonus (HP:0011448) | 3.55478829 |
| 13 | Absence seizures (HP:0002121) | 3.49101117 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.46187109 |
| 15 | Limb dystonia (HP:0002451) | 3.45305359 |
| 16 | Depression (HP:0000716) | 3.34637065 |
| 17 | Postural instability (HP:0002172) | 3.31552184 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.25556315 |
| 19 | Dialeptic seizures (HP:0011146) | 3.20931858 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.07303163 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.06502866 |
| 22 | Poor eye contact (HP:0000817) | 3.06246249 |
| 23 | Peripheral hypomyelination (HP:0007182) | 3.05229532 |
| 24 | Impaired social interactions (HP:0000735) | 3.03267980 |
| 25 | Abnormal social behavior (HP:0012433) | 3.03267980 |
| 26 | Papilledema (HP:0001085) | 3.02662634 |
| 27 | Akinesia (HP:0002304) | 3.01731995 |
| 28 | Genetic anticipation (HP:0003743) | 2.95220028 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.94091420 |
| 30 | Abnormal eating behavior (HP:0100738) | 2.92843232 |
| 31 | Hemiplegia (HP:0002301) | 2.89371099 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.88540741 |
| 33 | Truncal ataxia (HP:0002078) | 2.79099731 |
| 34 | Dysmetria (HP:0001310) | 2.78290423 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.77791064 |
| 36 | Diplopia (HP:0000651) | 2.68835665 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.68835665 |
| 38 | Anxiety (HP:0000739) | 2.66479978 |
| 39 | Urinary urgency (HP:0000012) | 2.65197551 |
| 40 | Tetraplegia (HP:0002445) | 2.64925358 |
| 41 | Torticollis (HP:0000473) | 2.64864399 |
| 42 | Broad-based gait (HP:0002136) | 2.64654404 |
| 43 | Diminished motivation (HP:0000745) | 2.64229048 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.62749111 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.61315145 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.60954051 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.56555651 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.55434178 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.55220528 |
| 50 | Dysmetric saccades (HP:0000641) | 2.54561150 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.53749008 |
| 52 | Delusions (HP:0000746) | 2.50342434 |
| 53 | Spastic gait (HP:0002064) | 2.49158909 |
| 54 | Drooling (HP:0002307) | 2.47960284 |
| 55 | Excessive salivation (HP:0003781) | 2.47960284 |
| 56 | Intention tremor (HP:0002080) | 2.47877173 |
| 57 | Bradykinesia (HP:0002067) | 2.43197061 |
| 58 | Hemiparesis (HP:0001269) | 2.40884425 |
| 59 | Status epilepticus (HP:0002133) | 2.36042520 |
| 60 | Spastic tetraparesis (HP:0001285) | 2.33456784 |
| 61 | Focal dystonia (HP:0004373) | 2.32379061 |
| 62 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.32277165 |
| 63 | Hand muscle atrophy (HP:0009130) | 2.31571978 |
| 64 | Sleep apnea (HP:0010535) | 2.30576624 |
| 65 | Insomnia (HP:0100785) | 2.30339571 |
| 66 | Progressive inability to walk (HP:0002505) | 2.30085968 |
| 67 | Bundle branch block (HP:0011710) | 2.27959704 |
| 68 | Lower limb muscle weakness (HP:0007340) | 2.27572808 |
| 69 | Agitation (HP:0000713) | 2.26426347 |
| 70 | Pointed chin (HP:0000307) | 2.22253377 |
| 71 | Stereotypic behavior (HP:0000733) | 2.20932108 |
| 72 | Amblyopia (HP:0000646) | 2.18200119 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.16970459 |
| 74 | Lower limb amyotrophy (HP:0007210) | 2.16632155 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13602579 |
| 76 | Scanning speech (HP:0002168) | 2.11288094 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.11239339 |
| 78 | Polyphagia (HP:0002591) | 2.10942857 |
| 79 | Craniofacial dystonia (HP:0012179) | 2.09660299 |
| 80 | Spastic tetraplegia (HP:0002510) | 2.09400534 |
| 81 | Rapidly progressive (HP:0003678) | 2.09173218 |
| 82 | Insidious onset (HP:0003587) | 2.06929613 |
| 83 | Termporal pattern (HP:0011008) | 2.06929613 |
| 84 | Hypsarrhythmia (HP:0002521) | 2.06750396 |
| 85 | Abnormality of the periventricular white matter (HP:0002518) | 2.06669358 |
| 86 | Megalencephaly (HP:0001355) | 2.06610035 |
| 87 | Pheochromocytoma (HP:0002666) | 2.06532612 |
| 88 | Amyotrophic lateral sclerosis (HP:0007354) | 2.05671703 |
| 89 | Abnormality of the corticospinal tract (HP:0002492) | 2.05358723 |
| 90 | Inappropriate behavior (HP:0000719) | 2.04627269 |
| 91 | Apathy (HP:0000741) | 2.02539287 |
| 92 | CNS hypomyelination (HP:0003429) | 2.01754458 |
| 93 | Annular pancreas (HP:0001734) | 2.00683768 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00122093 |
| 95 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00122093 |
| 96 | Clonus (HP:0002169) | 1.97069174 |
| 97 | Rigidity (HP:0002063) | 1.96586812 |
| 98 | Hypoplasia of the corpus callosum (HP:0002079) | 1.95935090 |
| 99 | Fetal akinesia sequence (HP:0001989) | 1.95736439 |
| 100 | Abnormality of saccadic eye movements (HP:0000570) | 1.95305347 |
| 101 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94617095 |
| 102 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94492918 |
| 103 | Resting tremor (HP:0002322) | 1.94203890 |
| 104 | Absent speech (HP:0001344) | 1.93585112 |
| 105 | Global brain atrophy (HP:0002283) | 1.93322002 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90430782 |
| 107 | Hyperventilation (HP:0002883) | 1.90157671 |
| 108 | Paraplegia (HP:0010550) | 1.89963296 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 1.88749751 |
| 110 | Upper limb amyotrophy (HP:0009129) | 1.88749751 |
| 111 | Dementia (HP:0000726) | 1.87881751 |
| 112 | Abnormal EKG (HP:0003115) | 1.87123328 |
| 113 | Macroorchidism (HP:0000053) | 1.86680688 |
| 114 | Hammertoe (HP:0001765) | 1.85640454 |
| 115 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85625100 |
| 116 | Hypercortisolism (HP:0001578) | 1.85244826 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.83851335 |
| 118 | Psychosis (HP:0000709) | 1.83742548 |
| 119 | Gait ataxia (HP:0002066) | 1.82798855 |
| 120 | Postural tremor (HP:0002174) | 1.82178556 |
| 121 | Failure to thrive in infancy (HP:0001531) | 1.81703877 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77741352 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77741352 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77741352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.18367361 |
| 2 | NTRK3 | 3.99807850 |
| 3 | EPHA4 | 3.37175268 |
| 4 | MARK1 | 3.05923254 |
| 5 | DAPK2 | 3.01339469 |
| 6 | MAP3K4 | 2.66139214 |
| 7 | MINK1 | 2.55645719 |
| 8 | PAK6 | 2.53955933 |
| 9 | KSR2 | 2.30188805 |
| 10 | CAMKK1 | 2.26895741 |
| 11 | PRKD3 | 2.25881078 |
| 12 | NTRK2 | 2.01223125 |
| 13 | NTRK1 | 1.89969979 |
| 14 | MAP2K7 | 1.86228391 |
| 15 | RIPK4 | 1.82736398 |
| 16 | MAP2K4 | 1.75455797 |
| 17 | STK38 | 1.72777489 |
| 18 | CDK5 | 1.52967853 |
| 19 | DAPK1 | 1.45878048 |
| 20 | SIK2 | 1.45118460 |
| 21 | CAMKK2 | 1.39846184 |
| 22 | KSR1 | 1.37542115 |
| 23 | PHKG2 | 1.35474855 |
| 24 | PHKG1 | 1.35474855 |
| 25 | RIPK1 | 1.35437740 |
| 26 | MAP3K2 | 1.34393367 |
| 27 | TAOK1 | 1.31724836 |
| 28 | MAP3K13 | 1.27232829 |
| 29 | LMTK2 | 1.23825035 |
| 30 | FES | 1.21236031 |
| 31 | PRKCH | 1.18130857 |
| 32 | CAMK1G | 1.17277845 |
| 33 | GRK5 | 1.15980961 |
| 34 | SCYL2 | 1.14768482 |
| 35 | MAP3K12 | 1.13359924 |
| 36 | PLK2 | 1.11790805 |
| 37 | PRPF4B | 1.10365398 |
| 38 | PRKCG | 1.08744888 |
| 39 | SGK3 | 1.06821168 |
| 40 | RET | 1.06005517 |
| 41 | TYRO3 | 1.04988695 |
| 42 | ALK | 1.03359710 |
| 43 | SGK494 | 1.02661752 |
| 44 | SGK223 | 1.02661752 |
| 45 | TRIB3 | 0.96878693 |
| 46 | CAMK1 | 0.95531677 |
| 47 | SGK2 | 0.93733351 |
| 48 | LATS2 | 0.92890835 |
| 49 | NEK1 | 0.92326547 |
| 50 | PKN1 | 0.91347525 |
| 51 | UHMK1 | 0.90036874 |
| 52 | EPHA3 | 0.88149975 |
| 53 | STK11 | 0.87229991 |
| 54 | CDK19 | 0.86269894 |
| 55 | MAPK13 | 0.85745307 |
| 56 | ARAF | 0.84997161 |
| 57 | PAK3 | 0.82338439 |
| 58 | PDPK1 | 0.80134215 |
| 59 | CAMK2G | 0.79983815 |
| 60 | PDK1 | 0.79879073 |
| 61 | MARK2 | 0.79084987 |
| 62 | MAP3K11 | 0.78359086 |
| 63 | SGK1 | 0.76068957 |
| 64 | CDC42BPA | 0.75587171 |
| 65 | CDK15 | 0.75349662 |
| 66 | CDK18 | 0.75245371 |
| 67 | MAP3K1 | 0.73496649 |
| 68 | PINK1 | 0.72377955 |
| 69 | CAMK2A | 0.71405870 |
| 70 | CDK14 | 0.71018066 |
| 71 | NEK6 | 0.70571961 |
| 72 | CAMK1D | 0.68620113 |
| 73 | PTK2B | 0.66169976 |
| 74 | TNIK | 0.65096094 |
| 75 | MAP3K7 | 0.65029784 |
| 76 | CASK | 0.64057369 |
| 77 | CDK11A | 0.62601032 |
| 78 | CSNK1A1L | 0.61733648 |
| 79 | CAMK4 | 0.61346654 |
| 80 | RPS6KA2 | 0.60307091 |
| 81 | FER | 0.59185017 |
| 82 | WNK1 | 0.57462441 |
| 83 | PRKCZ | 0.56912763 |
| 84 | FYN | 0.56784597 |
| 85 | RPS6KA3 | 0.55856538 |
| 86 | CSNK1G3 | 0.55470348 |
| 87 | DYRK1A | 0.52373317 |
| 88 | DAPK3 | 0.51870571 |
| 89 | ICK | 0.51374758 |
| 90 | OXSR1 | 0.49490723 |
| 91 | CSNK1G2 | 0.49370333 |
| 92 | MAPK10 | 0.48477052 |
| 93 | RAF1 | 0.47562750 |
| 94 | BCR | 0.47321348 |
| 95 | ERBB2 | 0.46719110 |
| 96 | MAP2K6 | 0.46695588 |
| 97 | LIMK1 | 0.46572769 |
| 98 | PNCK | 0.44489665 |
| 99 | PDGFRA | 0.44237583 |
| 100 | TNK2 | 0.44125162 |
| 101 | CAMK2B | 0.43822121 |
| 102 | MAP2K1 | 0.43590817 |
| 103 | JAK2 | 0.43550644 |
| 104 | FGFR2 | 0.43217516 |
| 105 | PRKCE | 0.42894459 |
| 106 | DMPK | 0.40830941 |
| 107 | BMX | 0.39820085 |
| 108 | MAPK12 | 0.39607131 |
| 109 | PKN2 | 0.38438938 |
| 110 | DYRK2 | 0.37877313 |
| 111 | DYRK1B | 0.35542036 |
| 112 | PTK2 | 0.35510250 |
| 113 | PRKG1 | 0.35248412 |
| 114 | JAK1 | 0.35096100 |
| 115 | PRKG2 | 0.34380632 |
| 116 | AKT3 | 0.34155569 |
| 117 | MAP3K6 | 0.34088337 |
| 118 | PRKAA1 | 0.33206168 |
| 119 | MAPK8 | 0.32973546 |
| 120 | CAMK2D | 0.32179430 |
| 121 | SRC | 0.32105774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26165312 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.92570076 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.52301826 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.43303892 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.38572470 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30176443 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21409625 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.18168288 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.17708967 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17374227 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.93309192 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.93182211 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.92169915 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.83131989 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79059102 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75113773 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74239799 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62069961 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61108940 |
| 20 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54504160 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49472954 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48110932 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47099346 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.46900909 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.46375658 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38526810 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37124705 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.35211746 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.34952256 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34803031 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31907586 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21555704 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20410739 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.19177583 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18868095 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.17275922 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16638070 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13385509 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12827919 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10271565 |
| 41 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07375626 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02925818 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97127383 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96612755 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96076339 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93288959 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90389671 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88531588 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.87020201 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86068641 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85554386 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84101054 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.83490007 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82349341 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80952736 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78682705 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77523172 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.74697175 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74154909 |
| 60 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72491211 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.69444161 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69063090 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68361163 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67484211 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65898491 |
| 66 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65368979 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.64467304 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63884941 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61782750 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61018494 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60055967 |
| 72 | * Lysosome_Homo sapiens_hsa04142 | 0.59970306 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59396458 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58694027 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58410698 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57664876 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55905203 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55148017 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53562187 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53498607 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53264845 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52962283 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52551896 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.52077537 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.51562219 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50859333 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50110704 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.49992176 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49756909 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49463695 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49161220 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48012265 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45869102 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45633077 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45630637 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45550175 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45162446 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45113731 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44258462 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44036872 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43553077 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42742153 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42611574 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41874613 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40572435 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39517802 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37596078 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37514260 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36746746 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36712085 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36659243 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.36004792 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35313085 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32665703 |
| 115 | * Phagosome_Homo sapiens_hsa04145 | 0.32257724 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29309938 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27261977 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25770721 |

